Trial Information
Summary: Registry Study for Patients Taking Hectorol ®
People with stage 3 and 4 chronic kidney disease are asked to
participate in a research study being conducted by Montefiore
Medical Center. Information will be collected during the normal
course of treatment with Hectorol. The purpose of this project is
to learn how to best treat secondary hyperparathyroidism in
patients with chronic kidney disease.
You may be eligible to participate in this study if
you:
- Are male or female at least 18 years of age
- Have stage 3 or 4 chronic kidney disease
- Are beginning treatment with Hectorol ® capsules
You may not participate in this study if
you:
- Have used Hectorol ® in the past
- Are pregnant
|
Contact:
Judith Gautier, PA, Study Coordinator
Biomedical Research Alliance of New York
Montefiore Medical Center
1515 Blondell Avenue
Bronx, NY 10461
Telephone: 718-597-2255
Fax: 718-792-4437
Email:
|
|

If you would like to learn more about participating in this study, please send an e-mail message using the form below.
Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.
This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.
Trial listings updated: June 1, 2008 at 5:44:54 AM